Triprolidine
| Triprolidine | |
|---|---|
| Salts [] | |
|---|---|
| Triprolidine hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 278.40 g/mol [1] |
| Appearance | Crystals from light petroleum [1] |
| Melting point | 60 °C [1] |
| Solubility | 74.9 mg/L [1] |
| Predicted LogP | 3.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C19H22N2 |
| IUPAC name | 2-[(E)-1-(4-methylphenyl)-3-pyrrolidin-1-ylprop-1-enyl]pyridine |
| SMILES | CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC=N3 |
| InChI | InChI=1S/C19H22N2/c1-16-7-9-17(10-8-16)18(19-6-2-3-12-20-19)11-15-21-13-4-5-14-21/h2-3,6-12H,4-5,13-15H2,1H3/b18-11+ |
| InChIKey | CBEQULMOCCWAQT-WOJGMQOQSA-N |
| CAS number | 486-12-4 |
| UNII | 2L8T9S52QM |
| PubChem CID | 5282443 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 4–6 hours |
| Metabolism | Hepatic (CYP2D6) |
| Excretion | Renal |
| Routes of administration | By mouth |
Triprolidine (also known as Triprolidin, Actidil, Tripolidina, Triprolidinum, Triprolidina, trans-1-(2-Pyridyl)-3-pyrrolidino-1-p-tolylprop-1-ene, Nci-c61450, trans-1-(4-Methylphenyl)-1-(2-pyridyl)-3-pyrrolidinoprop-1-ene, 2-[(1E)-1-(4-methylphenyl)-3-(pyrrolidin-1-yl)prop-1-en-1-yl]pyridine or Pyridine, 2-(3-(1-pyrrolidinyl)-1-p-tolylpropenyl)-, (E)-) is a substance of the phenethylamine class.
Chemistry
Salts []
Triprolidine is typically found in the form of its hydrochloride salt.
Stereochemistry []
Triprolidine is achiral.
Druglikeness
Lipinski's rule of five
Triprolidine matches Lipinski's rule of five.Pharmacology
ATC Classification
- respiratory system (R)
- antihistamines for systemic use (R06)
- antihistamines for systemic use (R06A)
- other antihistamines for systemic use (R06AX)
- triprolidine (R06AX07)
MeSH Classification
Mechanism of action []
Triprolidine binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. [1]
Interactions []
Experience reports
Legal status []
- United States: Triprolidine is a otc.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5282443, Triprolidine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5282443
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Triprolidine. UNII: 2L8T9S52QM. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/2L8T9S52QM
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 08:59:11 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 08:59:07 |
| erowid | ok | 2026-11-20 08:59:12 |
| gsrs | ok | 2026-11-20 08:59:08 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0014571) | 2026-11-20 08:59:07 |
| kegg | ok | 2026-11-20 08:59:09 |
| pubchem | ok | 2026-11-20 08:59:06 |
| missing (no r/tripreports posts mention it) | 2026-11-20 08:59:07 | |
| sider | missing (not in SIDER) | 2026-11-20 08:59:07 |
| structure | ok | 2026-11-20 08:59:07 |
| wikipedia | ok | 2026-11-20 08:59:07 |